Amygdala Neuroscience is a company that develops therapies designed to cure addiction. Its therapies include a selective ALDH2 inhibitor that prevents a surge in dopamine levels associated craving without changes to basal dopamine, enabling patients to quit and get rid of addiction to drugs, alcohol, and smoking.